Clinical and Virologic Characterization of Acyclovir‐Resistant Varicella‐Zoster Viruses Isolated from 11 Patients with Acquired Immunodeficiency Syndrome

Citations Over TimeTop 22% of 2001 papers

Abstract

We studied the clinical resistance to acyclovir of infections with varicella-zoster viruses (VZV) in patients with acquired immunodeficiency syndrome, and we correlated it to virologic analyses. Eleven patients with VZV infections (treated with acyclovir, 30 mg/kg/day, given intravenously, or 4 g/day, given orally) were included in the study because of the failure of 10 days of acyclovir therapy. Susceptibility of VZV isolates to acyclovir was tested using a plaque reduction assay to determine the 50% inhibitory concentration (IC(50)) of acyclovir and the SI(50) (IC(50) of the patient isolate/IC(50) of the reference strain) to acyclovir. The thymidine kinase (TK) gene, which supports the resistance, was sequenced on amplified products. Only 3 patients had a significant increase in the IC(50), as compared with the IC(50) of the reference strain (SI(50) of > or =4), and a mutation in the TK gene. For the other 8 patients, the clinical resistance was not confirmed by the virologic results: the SI(50) was < 4, and no mutation was detected in the TK gene. Because no acyclovir-resistant strain appeared during a shorter period of time, we suggest an increase in the duration of the treatment to 21 days before acyclovir resistance is suspected.

Related Papers

• → Polymerase Chain Reaction Detection and Clinical Significance of Varicella‐Zoster Virus in Cerebrospinal Fluid from Human Immunodeficiency Virus‐Infected Patients(1997)51 cited
• → Neurological Complications of Varicella-Zoster Virus in Human Immunodeficiency Virus-Infected Patients: Changes in Prevalence and Diagnostic Utility of Polymerase Chain Reaction in Cerebrospinal Fluid(2003)21 cited
• → Comparison of antiviral assay methods using cell-free and cell-associated varicella-zoster virus(1992)29 cited
• Splenectomy and prognosis of HIV infection. Group d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA)(1996)
• → Neurological Complications of Varicella-Zoster Virus in Human Immunodeficiency Virus-Infected Patients: Changes in Prevalence and Diagnostic Utility of Polymerase Chain Reaction in Cerebrospinal Fluid(2003)